David Cipolla

3.4k citations
89 papers · 2.7k · h-index 30

Impact in

Papers in

    • Inhalation and Respiratory Drug Delivery 38
    • Cystic Fibrosis Research Advances 22
    • Pulmonary Hypertension Research and Treatments 8
    • Neonatal Respiratory Health Research 7
    • Advanced Drug Delivery Systems 11
    • Drug Solubulity and Delivery Systems 8

David Cipolla

83 papers receiving 2.5k citations

Peers

David Cipolla
Comparison fields: 5 of 139
  • Pharmaceutical Science 751
  • Pulmonary and Respiratory Medicine 1.6k
  • Biomaterials 353
  • Molecular Medicine 119
  • Food Science 259
Replace Francesca Buttini with:
Francesca Buttini Italy
Heidi M. Mansour United States
Philip Chi Lip Kwok Australia
Rita Vanbever Belgium
Rahul Kumar Verma India
Jason T. McConville United States
Lucila Garcia‐Contreras United States
Amit Misra India
Abdelbary Elhissi United Kingdom
Agnese Miro Italy
David Cipolla relative to Francesca Buttini Italy Francesca Buttini's profile →
Citations per field
00.5×1.5×
Francesca Buttini · 1×
Citations per year

Countries citing papers authored by David Cipolla

Since Specialization
Citations

This map shows the geographic impact of David Cipolla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cipolla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cipolla more than expected).

Fields of papers citing papers by David Cipolla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cipolla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cipolla. The network helps show where David Cipolla may publish in the future.

Co-authors

The 25 scholars most cited alongside David Cipolla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Cipolla Line = papers co-authored together David Cipolla links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2007202
2 2013198
3 2016153
4 2019138
5 2013132
6 2018125
7 2014114
8 201093
9 202289
10 201273
11 202166
12 201462
13 201958
14 200151
15 201351
16 201349
17 201349
18 201944
19 201144
20 202143

About David Cipolla

David Cipolla is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science, Physiology, Molecular Biology and Biomaterials, having authored 89 papers that have together received 2.7k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (38 papers), Cystic Fibrosis Research Advances (22 papers), Advanced Drug Delivery Systems (11 papers), Nanoparticle-Based Drug Delivery (10 papers), Asthma and respiratory diseases (9 papers), Drug Solubulity and Delivery Systems (8 papers), Pulmonary Hypertension Research and Treatments (8 papers) and Neonatal Respiratory Health Research (7 papers). The work is most often cited by research in Pharmaceutical Science (751 citations), Pulmonary and Respiratory Medicine (1.6k citations), Biomaterials (353 citations), Molecular Medicine (119 citations) and Food Science (259 citations). David Cipolla has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Igor Gonda, Hak‐Kim Chan, Jim Blanchard, Ben J. Boyd, Boris Y. Shekunov, Thomas Rades, Anthony J. Hickey, Qi Zhou, Nivedita Shetty and Heejun Park. Their work appears in journals such as Journal of Aerosol Medicine and Pulmonary Drug Delivery, Pharmaceutical Research, Pharmaceutics, International Journal of Pharmaceutics and European Journal of Pharmaceutics and Biopharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact